THE MCMANUS GROUP for GENENTECH
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Parts B and D reform. Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act and Senate reconciliation bill.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| ALANNA TEMME | — |
Copyright/Patent/Trademark CPT
Issues related to proposed WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Waiver of COVID-19 products (IP/C/W/669/Rev.1).
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas |
| ALANNA TEMME | LD, Rep. Jon Porter |
Budget/Appropriations BUD
Support for increased investments to address antimicrobial resistance. Awareness and appropriations related to influenza.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | Staff Director, W&M Health Subcommittee; LA, Rep. Bill Thomas |
| ALANNA TEMME | LD, Rep. Jon Porter |
Health Issues HCR
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas |
| ALANNA TEMME | LD, Rep. Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.